Stock listing

NYSE:MYOV Myovant Sciences Ltd Stock

Follow Myovant Sciences Ltd into a list and get an email when it puts out news.

Last close · NYSE:MYOV

$26.98 USD

Close on Mar 9, 2023 · No longer trades

Oct 27, 2016 to last close +103.5% · weekly closes, Oct 27, 2016 – Mar 9, 2023
Lowest – highest close
$4.20 – $27.62 USDSince Oct 27, 2016 · lowest Oct 28, 2019 · highest Dec 31, 2020

Delisted NYSE:MYOV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NYSE:MYOV
Asset type
Stock
Exchange
NYSE
Currency
USD

Myovant Sciences Ltd on 6ix

Decks
1 deck · latest May 14, 2019

Decks

DeckKindSlidesDate
Technical Presentation (May 2019)Technical21 slidesMay 14, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Myrtle S Potter
Other companies: Ginkgo Bioworks Holdings, Inc. (Director · Since at least Jun 13, 2024); Guardant Health, Inc. (Director · Since at least Oct 15, 2021); Immunovant, Inc. (Director · Dec 18, 2019 – Dec 18, 2019 · Past); Arbutus Biopharma Corporation (Director · Oct 18, 2018 – Aug 17, 2019 · Past); Sio Gene Therapies Inc (Director · Sep 26, 2018 – Apr 15, 2019 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Mar 29, 2021 · Past); Axsome Therapeutics, Inc. (Director · Jun 16, 2017 – Jun 7, 2019 · Past); Insmed Incorporated (Director · Dec 11, 2014 – May 15, 2018 · Past); Everyday Health Inc (Director · Mar 27, 2014 – Dec 3, 2016 · Past); Rite Aid Corporation (Director · Nov 29, 2013 – Oct 3, 2017 · Past)
Director · Sep 20, 2018 – Mar 10, 2023 · Past
Frank Karbe
Other companies: Cidara Therapeutics Inc (Chief Financial Officer · Since at least Feb 24, 2025); Phathom Pharmaceuticals, Inc. (Director · Since at least Apr 25, 2022); Better Therapeutics, Inc. (Chief Executive Officer, Director · Jul 5, 2022 – Dec 18, 2023 · Past); Aduro Biotech Inc (Director · Apr 18, 2019 – May 5, 2020 · Past); Arbutus Biopharma Corporation (Director · Dec 31, 2014 – Jun 21, 2017 · Past); Exelixis, Inc. (EVP and CFO · Dec 8, 2006 – Feb 15, 2014 · Past)
Principal Fin'l & Accounting · Oct 26, 2016 – Jul 7, 2021 · Past
Frank Torti
Other companies: Roivant Sciences Ltd. (President and Vant Chair · Since at least Jul 29, 2025); Immunovant, Inc. (Director · Since at least Dec 18, 2019); Arbutus Biopharma Corporation (Director · Nov 26, 2018 – May 23, 2024 · Past); Sio Gene Therapies Inc (Director · Sep 26, 2018 – Apr 15, 2021 · Past); Urovant Sciences Ltd (Director · Sep 26, 2018 – Jul 9, 2019 · Past)
Director · Nov 6, 2018 – Aug 23, 2019 · Past
Wayne S. DeVeydt
Other companies: UnitedHealth Group Incorporated (Chief Financial Officer · Since at least Jul 31, 2025); Centene Corporation (Director · Since at least Jan 5, 2022); Surgery Partners, Inc. (Exec Chairman of the Board, Director · Jan 4, 2018 – Mar 21, 2025 · Past); NiSource Inc (Director · Mar 22, 2016 – May 25, 2021 · Past); Elevance Health, Inc. (EVP & Chief Financial Officer · Mar 1, 2006 – Mar 3, 2016 · Past)
Director · Oct 26, 2016 – Aug 18, 2017 · Past
Adele M. Gulfo
Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Apr 15, 2025); Tyra Biosciences, Inc. (Board Member · Since at least Jan 29, 2025); Enpro Inc. (Director · Since at least Oct 30, 2018); Bemis Company Inc (Director · Jun 23, 2015 – Jun 11, 2019 · Past)
Director · Dec 27, 2019 – Mar 10, 2023 · Past
Lynn Seely
Other companies: AbCellera Biologics Inc. (Director · Since at least Jun 30, 2026); Lyell Immunopharma, Inc. (President and CEO, Director · Since at least Jun 16, 2021); Blueprint Medicines Corp (Director · Since at least Jun 19, 2019)
Principal Executive Officer, Director · Apr 5, 2019 – Apr 3, 2020 · Past
Mark Guinan
Other companies: UpHealth, Inc. (Director · Jan 31, 2024 – Jan 31, 2024 · Past); Quest Diagnostics Incorporated (Executive Vice President & CFO · Jul 29, 2013 – Mar 7, 2022 · Past); Hill-Rom Holdings Inc (Sr. VP & CFO · Dec 13, 2010 – Dec 14, 2012 · Past)
Director · Jul 23, 2018 – Mar 10, 2023 · Past
Matthew Lang
Other companies: Structure Therapeutics, Inc. (COO & GC · Since at least Apr 15, 2026); Metsera, Inc. (CHIEF LEGAL OFFICER · Since at least Apr 28, 2025); Lyell Immunopharma, Inc. (Chief Business Officer · Jul 1, 2023 – Feb 10, 2025 · Past)
General Counsel & Corp. Secy. · Apr 5, 2019 – Mar 10, 2023 · Past
Terrie Curran
Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Nov 2, 2020); Phathom Pharmaceuticals, Inc. (President and Chief Executive, Director · Oct 24, 2019 – Feb 27, 2025 · Past); Celgene Corporation (PRES., GLBL INFLAM. AND IMMUN. · Jun 14, 2017 – Nov 20, 2019 · Past)
Director · Nov 15, 2016 – Mar 10, 2023 · Past
Vivek Ramaswamy
Other companies: Roivant Sciences Ltd. (Founder · Since at least Oct 1, 2021); Sio Gene Therapies Inc (Principal Executive Officer, Director · Jun 10, 2015 – Apr 29, 2016 · Past); Arbutus Biopharma Corporation (Director · Mar 4, 2015 – Jun 19, 2018 · Past)
Director · Oct 26, 2016 – Oct 26, 2016 · Past
All 22 people
PersonSeat
David C Marek
Other companies: Axsome Therapeutics, Inc. (Chief Commercial Officer · Sep 4, 2019 – Mar 17, 2020 · Past); WebMD Health Corp (Executive Vice President · Sep 4, 2012 – Sep 4, 2013 · Past)
Principal Executive Officer, Director · Jan 4, 2021 – Mar 10, 2023 · Past
Kathleen Sebelius
Other companies: Humacyte, Inc. (Chair of the Board · Since at least Aug 26, 2021); EXACT Sciences Corporation (Director · Mar 3, 2019 – Jun 13, 2024 · Past)
Director · Oct 26, 2016 – Sep 15, 2020 · Past
Keith Manchester M.D.
Other companies: Roivant Sciences Ltd. (Audit Committee Member · Since at least Oct 1, 2021); Arbutus Biopharma Corporation (Director · Mar 4, 2015 – Aug 14, 2024 · Past)
Director · Oct 26, 2016 – Oct 26, 2016 · Past
Kim Sablich
Other companies: Eiger Biopharmaceuticals Inc (Director · Apr 23, 2021 – Mar 1, 2023 · Past); Jazz Pharmaceuticals plc (EVP, GM of U.S. · Jun 1, 2020 – Jun 5, 2023 · Past)
Chief Commercial Officer · Dec 1, 2018 – Apr 3, 2020 · Past
Lauren Merendino
Other companies: Day One Biopharmaceuticals Inc (Chief Commercial Officer · Since at least Feb 26, 2025); ESSA Pharma Inc (Director · Jun 6, 2023 – Mar 25, 2024 · Past)
Chief Commercial Officer · Apr 5, 2021 – Mar 10, 2023 · Past
Mark Altmeyer
Other companies: Alector, Inc. (Board Member · Since at least Mar 19, 2024); Sio Gene Therapies Inc (Pres (ASG) & Chief Comm. Ofc. · Jun 10, 2015 – Mar 15, 2018 · Past)
Director · Oct 26, 2016 – Aug 31, 2018 · Past
Uneek Mehra
Other companies: BridgeBio Oncology Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 11, 2025); 4D Molecular Therapeutics, Inc. (See Remarks · Sep 22, 2023 – Mar 6, 2025 · Past)
Principal Financial Officer · Sep 7, 2021 – Mar 10, 2023 · Past
Ferreira Juan Camilo Arjona
Other companies: Organon & Co. (Head of R&D & CMO · Since at least Jan 1, 2024)
Chief Medical Officer · Jul 24, 2017 – Mar 10, 2023 · Past
Hiroshi Nomura
Other companies: Roivant Sciences Ltd. (Director · Sep 16, 2022 – Sep 16, 2022 · Past)
Director · Dec 27, 2019 – Dec 27, 2019 · Past
Marianne L Romeo
Other companies: Sio Gene Therapies Inc (Head,Global Trans & Risk Mgmt, Director · Apr 29, 2016 – Apr 29, 2016 · Past)
Head,Global Trans. & Risk Mgmt · Oct 26, 2016 – Oct 26, 2016 · Past
Nancy Valente
Other companies: Xencor, Inc. (EVP, Chief Development Officer · Sep 8, 2022 – May 2, 2025 · Past)
Director · Nov 5, 2021 – Mar 10, 2023 · Past
Shigeyuki Nishinaka
Other companies: Urovant Sciences Ltd (Director · Dec 27, 2019 – Dec 27, 2019 · Past)
Director · Oct 21, 2022 – Oct 21, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about Myovant Sciences Ltd.